Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.

Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function ...

Profound Medical ( ($TSE:PRN) ) has shared an announcement. Profound Medical announced that The Johns Hopkins Hospital has performed its first ...

Investors who take an interest in Profound Medical Corp. (TSE:PRN) should definitely note that the Independent Director, Arthur L. Rosenthal, recently paid CA$10.01 per share to buy CA$139k worth of ...

TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private ...

TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) today announced the closing of its previously announced registered direct offering ...

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has increased the size of its private placement ...

Shares of Profound Medical declined after the medical-device company said it planned to increase the size of its private placement. The stock fell 2.5%, to $7.32, late Friday morning, and shares are ...